Hepatitis B immunoglobulin Behring Injection solution for intramuscular use Malta - English - Malta Medicines Authority

hepatitis b immunoglobulin behring injection solution for intramuscular use

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - human hepatitis, b immunoglobulin, human plasma, protein - solution for injection - human hepatitis b immunoglobulin 200 iu human plasma protein 100-170 mg - immune sera and immunoglobulins

Human Albumin = Human bioplazma Solution For Infusion Kenya - English - Pharmacy and Poisons Board

human albumin = human bioplazma solution for infusion

human bioplazma llc h-2100 godollo transics milhaly ut 80hungary - human albumin - solution for infusion - 20%human albumin - blood substitutes and plasma protein fractions

Intratect 100 g/l inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intratect 100 g/l inf. sol. i.v. vial

biotest pharma gmbh - human plasma proteins 100 mg/ml - solution for infusion - 100 g/l - human normal immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.

Intratect 100 g/L, solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

intratect 100 g/l, solution for infusion

biotest pharma gmbh - human plasma protein - solution for infusion - 100 gram(s)/litre - immunoglobulins, normal human; immunoglobulins, normal human, for intravascular adm.

CSL HEPATITIS B IMMUNOGLOBULIN VF (human) 400IU injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

csl hepatitis b immunoglobulin vf (human) 400iu injection vial

csl behring australia pty ltd - hepatitis b immunoglobulin, quantity: 400 iu; human immunoglobulin g, quantity: 160 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - hepatitis b immunoglobulin-vf is indicated for post-exposure prophylaxis in persons who did not receive prior vaccination, or whose prior vaccination regimen is incomplete, or when the hepatitis b antibody level is inadequate (<10iu/l). post-exposure prophylaxis should be considered following percutaneous or permucosal exposure to hbsag-positive or suspected hbsag-positive material, for example, by needle stick, oral ingestion or sexual exposure. hepatitis b immunoglobulin-vf is also indicated for prophylaxis in infants born to hbsag-positive mothers.

Gammaplex 10%100 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

gammaplex 10%100 mg/ml solution for infusion

bio products laboratory limited - human normal immunoglobulin - solution for infusion - 100 milligram(s)/millilitre - immunoglobulins, normal human; immunoglobulins, normal human, for intravascular adm.

Megalotect 100 U/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

megalotect 100 u/ml inf. sol. i.v. vial

biotest pharma gmbh - human cytomegalovirus immunoglobulin 100 u/ml - eq. human plasma proteins 50 mg/ml - solution for infusion - 100 u/ml - human anti-cytomegalovirus (cmv) immunoglobulin 100 u/ml; human protein plasma solution 50 mg/ml - cytomegalovirus immunoglobulin

KIOVIG 100 MGML Israel - English - Ministry of Health

kiovig 100 mgml

takeda israel ltd - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 100 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - ivig can be used in all age ranges, unless otherwise specified below.replacement therapy in:primary immunodeficiency syndromes with impaired antibody production.hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.children and adolescents (age 0-18) with congenital aids and recurrent bacterial infections.hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (hsct).immunomodulationprimary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.guillain barré syndrome.kawasaki disease.

Anbinex Powder For Injection 1000 I.U. Singapore - English - HSA (Health Sciences Authority)

anbinex powder for injection 1000 i.u.

grifols asia pacific pte. ltd. - human antithrombin - injection, powder, lyophilized, for solution - 1000 i.u. per 20ml - human antithrombin 1000 i.u. per 20ml

Human Albumin Baxalta 50 g/l Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

human albumin baxalta 50 g/l solution for infusion

baxalta innovations gmbh - plasma protein containing at least 95% human albumin - solution for infusion - 50 gram(s)/litre - blood substitutes and plasma protein fractions; albumin - plasma substitutes and plasma protein fractions - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.